Alternative Meds Get Federal Spotlight: NIH Integrative Health Chat
Published Date: 12/16/2025
Notice
Summary
The National Center for Complementary & Integrative Health is holding a virtual meeting on April 17, 2026, to review grant applications and share updates on their latest projects. This meeting affects researchers and the public interested in complementary health studies, with a chance to submit comments by April 3. It’s a key moment for funding decisions and learning about new health research, all happening online for easy access.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
NCCIH Grant Applications Reviewed April 17
The National Advisory Council for Complementary and Integrative Health will review and evaluate grant applications on April 17, 2026 during a virtual meeting. This meeting is a key step in funding decisions for researchers with pending NCCIH grant applications.
Public Comment Opportunity by April 3
Any interested person may submit written comments to the committee no later than April 3, 2026. Comments must be less than 700 words and include name, email, phone number, and, if applicable, professional affiliation.
Part of Meeting Closed for Confidential Matters
The meeting will be closed to the public from 10:00 a.m. to 12:00 p.m. on April 17, 2026 because grant discussions may disclose confidential trade secrets or personal information. The open session runs 12:30 p.m. to 5:00 p.m. and will be available virtually.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-22992, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding a closed virtual meeting on January 13-14, 2026, to review important grant applications about infectious diseases. These meetings are private to protect secret research info and personal details. Scientists applying for grants should note this review could impact funding decisions soon.
Next: 2025-22994, Sunshine Act Meetings
The Unified Carrier Registration Board is holding a meeting on December 18, 2025, open to the public for some parts and closed for others to protect sensitive info. This affects carriers and stakeholders involved in registration plans, with no new costs announced but important decisions on plan implementation expected. You can join by phone or Zoom, making it easy to stay in the loop!